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 ABSTRACT 
 
Edible mushrooms have been a common dietary source with not only unique 
taste and nutritional values, but also their additional health benefits. Research focus on 
the health benefits of mushrooms has shifted from medicinal mushrooms to edible 
mushrooms in recent years. Bioactive compounds, including polysaccharides, phenolic 
compounds, amino acids, functional proteins and peptides, indole compounds, and 
terpenoids, have been studied extensively. Some common health benefits of 
mushrooms discussed in different researches include immunomodulatory effect, 
antioxidant activity, anticancer effect, antibacterial activity, and anticholesterol 
activity. This report provides a comprehensive review of current research on edible 
mushrooms regarding their major nutrients, bioactive compounds and health benefits. 
Three groups of bioactive compounds: beta-glucans, phenolic compounds and L-
ergothioneine, are reviewed in detail. Anti-cancer activity, immunomodulatory effect 
and prebiotic potential are covered for beta-glucans. Antioxidant activity and 
antimicrobial activity are covered for phenolic compounds. Last but not least, 
antioxidant activity, cyto-protective effect and immunomodulatory effect are covered 
for L-ergothioneine. 
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CHAPTER 1 
 
INTRODUCTION 
Mushrooms have been an important dietary source in human foods for more than 
thousands of years. The special flavors and texture make mushrooms a popular culinary 
ingredient in many cuisines (Chatterjee et al., 2017; Kalač, 2016a; Valverde, Hernández-Pérez, 
& Paredes-López, 2015). According to the data from Food and Agriculture Organization 
Corporation Statistics Database (FAOSTAT), the world production of mushrooms and truffles in 
2014 reached more than 10.3 million metric tons (Kalač, 2016a) . The top 5 leading countries of 
producing and consuming mushrooms include China, Italy, the USA, the Netherland and Poland, 
with China producing far more amount than the rest (Feeney et al., 2014; Kalač, 2016a; Valverde 
et al., 2015).  
Mushrooms are not only consumed as a delicacy due to their great taste and rich nutrients 
but also used as ‘medicine’ to treat and prevent some diseases because of their medicinal 
properties (Chatterjee et al., 2017; Han, Ling, & Chen, 2015; Jayachandran, Xiao, & Xu, 2017; 
S. P. Wasser, 2014). The earliest use of mushrooms as medicine can be dated back to ancient 
China and ancient Egypt (Jayachandran et al., 2017). In a famous Chinese pharmacopeia 
Compendium of Materia Medica (Bencao Gangmu), there were records of medicinal values of 
mushrooms including both medicinal mushrooms and common edible mushrooms. Examples of 
medicinal mushrooms are Ganoderma lucidum (Lingzhi), Trametes versicolor (Yunzhi), and 
Cordyceps sinensis (Dongchong Xiacao) (Guggenheim, Wright, & Zwickey, 2014). Examples of 
edible mushrooms are Agaricus bisporus, Lentinula edodes, Pleurotus spp., Flammulina 
velutipes, Hericium erinaceus, Auricularia and so on (Kalač, 2016b, 2016c; Royse Daniel, 
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Baars, & Tan, 2017; Valverde et al., 2015). Early researches focused on purely medicinal 
mushrooms that are not commonly consumed in diet. But since many edible mushrooms also 
carry medicinal values, the number of scientific researches on edible mushrooms regarding their 
health benefits have increased significantly. In fact, it is not easy to separate medicinal 
mushrooms and edible mushrooms because many mushrooms are used both as food and 
medicine. Consuming mushrooms as functional food is becoming a popular trend. The health 
benefits of mushrooms include immunomodulatory, anti-allergic, antioxidant, anticancer, 
antidiabetic, antibacterial, cholesterol-lowering effect, and source of prebiotics for gut health 
(Chatterjee et al., 2017; Feeney et al., 2014; Jayachandran et al., 2017; Valverde et al., 2015; S. 
P. Wasser, 2014; J.-J. Zhang et al., 2016). The major contributors of these health effects are the 
bioactive compounds inside mushrooms including polysaccharides, phenolic compounds, free 
amino acid, indole compounds, free fatty acids, functional proteins, terpenoids and others 
(Chatterjee et al., 2017; Feeney et al., 2014; Kalač, 2016c; Valverde et al., 2015; S. P. Wasser, 
2014; J.-J. Zhang et al., 2016).  
The purpose of this review is to provide comprehensive information of three major 
bioactive compounds in mushrooms which are beta-glucan, phenolic compounds and L-
ergothioneine and their health benefits. This article is based on a few good reviews done by 
previous scientists (Feeney et al., 2014; Kalač, 2013; Rathore, Prasad, & Sharma, 2017; 
Valverde et al., 2015) and plenty of contemporary literatures on the health benefits of edible 
mushrooms. It is hoped that this article could allow both scholars and the general public have a 
quick understanding of the potential of edible mushrooms as a functional food.  
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CHAPTER 2 
 
COMMON EDIBLE MUSHROOM SPECIES 
Mushrooms belong to Kingdom Fungi and are consist of thousands of species, among 
which some are edible, some have medicinal uses but some are poisonous. There are more than 
2000 mushroom species reported to be edible but only about 35 species are commercially 
cultivated with around 20 are produced in industrial scale (Kalač, 2013; Sánchez, 2004, 2010; 
Valverde et al., 2015). According to the most current review of world mushroom production , 
Lentinus edodes is the most cultivated one, which accounted for around 22% of world mushroom 
cultivation in 2013, followed by Pleurotus spp., Auricularia spp., Agaricus bisporus and 
Flammulina velutipes (Royse Daniel et al., 2017). Table 1 shows the commons names, 
applications, and distribution of the most common edible mushrooms in the world.  
Table 1 Common Edible Mushrooms in the World 
Scientific names Common names Distribution Reference 
Agaricus bisporus Button mushroom 
(white/brown mushroom) 
Most cultivated 
species worldwide  
Hall, Buchanan, Cole, 
Yun, and Stephenson 
(2003); Morin et al. 
(2012); F. S. Reis, L. 
Barros, A. Martins, and 
I. C. Ferreira (2012); 
Valverde et al. (2015) 
Agaricus blazei Sun mushroom Native to Brazil; 
extensively cultivated 
in Japan  
Firenzuoli, Gori, and 
Lombardo (2008); Hall 
et al. (2003); Valverde et 
al. (2015) 
Lentinus edodes Shiitake mushroom Native to East Asia; 
extensively cultivated 
in Japan, China  
Bisen, Baghel, 
Sanodiya, Thakur, and 
Prasad (2010); Hall et al. 
(2003); Mizuno (1995); 
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Filipa S Reis et al. 
(2012); Royse Daniel et 
al. (2017); Sánchez 
(2010) 
Pleurotus ostreatus Oyster mushroom cultivated worldwide Hall et al. (2003); F. S. 
Reis, L. Barros, A. 
Martins, and I. C. F. R. 
Ferreira (2012); Sánchez 
(2010); Valverde et al. 
(2015) 
Pleurotus eryngii King oyster mushroom 
Pleurotus citrinopileatus Golden oyster mushroom Native to China, 
Japan, Korea and East 
Russia 
Hall et al. (2003); 
Jicheng Liu et al. 
(2012); J. Zhang et al. 
(1994) 
Volvariella volvacea Straw mushroom, paddy 
straw mushroom, Chinese 
mushroom 
Cultivated in East 
especially in China 
and Southeast Asia 
Bao et al. (2013); B. 
Chen et al. (2013); Hall 
et al. (2003); Sánchez 
(2010) 
Flammulina velutipes Enokitake, golden needle 
mushroom, winter 
mushroom 
Cultivated in East 
Asia; 
Wildly native to many 
countries 
Hall et al. (2003); Filipa 
S Reis et al. (2012); 
Sánchez (2010) 
 
Nutritional compositions and bioactive compounds 
Major macro- and micro-nutrients 
Mushrooms are high in water content and the dry matter normally range from 80 to140 
g/kg fresh matter (Kalač, 2013). Despite their low dry matter, they are good sources of many 
nutrients including proteins, fatty acids, vitamins and minerals, but low in calories due to low fat 
content. Many mushrooms are rich in proteins compared with most of the vegetables; they 
usually contain proteins around 200-250g/kg dry matter and some contain complete profile of 
amino acids with leucine, valine, glutamine, glutamic acid and aspartic acid as the most abundant 
ones (Valverde et al., 2015). Mushrooms also contain different types of monosaccharides and 
5 
 
their derivatives, oligosaccharides and polysaccharides (Kalač, 2013). Mannitol (28.9 g/kg dry 
matter) and trehalose (39.2 g/kg dry matter) are the most abundant free sugar alcohol and sugar 
in mushrooms respectively (Kalač, 2013). Polysaccharides are very important components in 
mushrooms due to their structural role in cell walls. 𝛽𝛽-glucans are probably the most well-
studied one due to their abundant health benefits, which will be discussed in details in the next 
section (Kalač, 2013). Most of the saccharides in mushrooms are not for calorie purpose because 
of their low digestibility but many of them attribute to great health benefits. Table 2 shows the 
approximate compositions and energy of some most commonly cultivated mushrooms.  
Apart from the macronutrients, mushrooms also contain different vitamins including 
riboflavin, niacin, folates, thiamin, vitamin B6, vitamin E and vitamin D (Valverde et al., 2015). 
They are the only natural non-animal source of vitamin D; wild mushrooms usually have more 
vitamin D than cultivated ones because they are exposed to UV-light more often (Kalač, 2013; 
Filipa S Reis et al., 2012; Valverde et al., 2015). Previous reports reported that mushrooms 
contained 3000-7000 mg/kg dry matter of ergosterol, which is the provitamin of ergocalciferol 
(Vitamin D2) (Mattila, Lampi, Ronkainen, Toivo, & Piironen, 2002; Phillips et al., 2011). The 
vitamin C content reported in some mushrooms is around 100 - 400 mg/100g dry matter. (Kalač, 
2013).  Tocopherol content is usually low in mushrooms however relatively high tocopherol 
value was reported in Boletus reticulatus (2.5 mg/100 g dry weight), Lycoperdon umbrinum 
(1.67 mg/100g dry weight) and Suillus variegatus (1.45 mg/100g dry weight) (Heleno et al., 
2011; Pereira, Barros, Martins, & Ferreira, 2012; Vaz et al., 2011). Different minerals are also 
found in mushrooms; some major mineral include sodium, potassium, calcium, magnesium, 
phosphorus, sulfur and chlorine (Kalač, 2013, 2016b; Valverde et al., 2015). Among these, 
potassium is the most abundant one, ranging from 2000 – 4000 mg/100g dry matter (Kalač, 
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2016b). Table 3 and 4 show the major minerals and vitamins in some most commonly cultivated 
mushrooms.  
Table 2 Proximate Compositions (g/100g FW) and Energy (kcal/100g fresh matter) of Common 
Edible Mushrooms  
Scientific 
names 
Common 
names 
Water 
content 
 
Protein Total 
lipids 
Total 
Carbohy
drates 
Ash Energy Reference 
Agaricus 
bisporus 
(white) 
Button 
mushroom 
92.45 3.09 0.34 3.26 0.85 22 (USDA, 
2018f) 
Agaricus 
bisporus 
(brown) 
Button 
mushroom 
92.12 2.50 0.10 4.30 0.98 22 (USDA, 
2018g) 
Agaricus 
blazei 
Sun 
mushroom 
NA 3.13 0.18 5.94 0.75 38 (Carneiro et 
al., 2013) 
Lentinus 
edodes 
Shiitake 89.74 2.24 0.49 6.79 0.73 34 (USDA, 
2018b) 
Pleurotus 
ostreatus 
Oyster 
mushroom 
89.18 3.31 0.41 6.09 1.01 33 (USDA, 
2018e) 
Pleurotus 
eryngii 
King oyster 
mushroom 
89 1.1 1.45 8.14 0.618 42 (Filipa S 
Reis et al., 
2012) 
Volvariella 
volvacea 
Straw 
mushroom 
89.88 3.83 0.68 4.64 0.97 32 (USDA, 
2018c) 
Flammulina 
velutipes 
Golden 
needle 
mushroom 
88.34 2.66 0.29 7.81 0.91 37 (USDA, 
2018d) 
Auricularia 
polytricha 
 
Jaw’s ear 92.56 0.48 0.04 6.75 0.15 25 (USDA, 
2018a) 
NA: not available  
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Table 3 Minerals (mg/100g FW) in Common Edible Mushrooms 
Scientific 
names 
Common 
names 
Ca Fe Mg P K Na Zn Reference 
Agaricus 
bisporus 
(white) 
Button 
mushroom 
3 0.5 9 86 318 5 0.52 (USDA, 
2018f) 
Agaricus 
bisporus 
(brown) 
Button 
mushroom 
18 0.40 9 120 448 6 1.10 (USDA, 
2018g) 
Lentinus 
edodes 
Shiitake 2 0.41 20 112 304 9 1.03 (USDA, 
2018b) 
Pleurotus 
ostreatus 
Oyster 
mushroom 
3 1.33 18 120 420 18 0.77 (USDA, 
2018e) 
Pleurotus 
eryngii 
King 
oyster 
mushroom 
3 NA 14 NA 309 5 NA (Filipa S 
Reis et al., 
2012) 
Flammulina 
velutipes 
Straw 
mushroom 
0 1.15 16 105 359 3 0.65 (USDA, 
2018d) 
Volvariella 
volvacea 
Golden 
needle 
mushroom 
10 1.43 7 61 78 384 0.67 (USDA, 
2018c) 
Auricularia 
polytricha 
 
Jaw’s ear 16 0.56 25 14 43 9 0.66 (USDA, 
2018a) 
NA: not available  
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Table 4 Vitamins in Common Edible Mushrooms 
Scientific 
names 
Common 
names 
Thiamin 
(mg/100g , 
FW) 
Riboflavin 
(mg/100g 
FW) 
Niacin 
(mg/100g 
FW) 
Vitamin 
B6 
(mg/100g 
FW) 
Folate 
(𝜇𝜇g/100g 
FW) 
Vitamin D 
(D2+D3) 
(𝜇𝜇g/100g 
FW) 
Ergosterol 
(mg/100g 
FW) 
Vitamin A 
(𝜇𝜇g/100g 
FW) 
Vitamin E 
(mg/100g 
FW) 
Reference 
Agaricus 
bisporus 
(white) 
Button 
mushroom 
0.081 0.402 3.607 0.104 17 0.2 56 0 0.01 (USDA, 
2018f) 
Agaricus 
bisporus 
(brown) 
Button 
mushroom 
0.095 0.490 3.800 0.110 25 0.1 62 0 0.01 (USDA, 
2018g) 
Lentinus 
edodes 
Shiitake 0.015 0.217 3.877 0.293 13 0.4 85 NA NA (USDA, 
2018b) 
Pleurotus 
ostreatus 
Oyster 
mushroom 
0.125 0.349 4.956 0.110 38 0.7 64 2 0 (USDA, 
2018e) 
Flammulina 
velutipes 
Golden 
needle 
mushroom 
0.225 0.200 7.032 0.100 48 0.1 36 0 0.01 (USDA, 
2018d) 
Volvariella 
volvacea 
Straw 
mushroom 
0.013 0.070 0.224 0.014 38 NA NA 0 NA (USDA, 
2018c) 
Auricularia 
polytricha 
 
Jaw’s ear 0.081 0.204 0.070 0.088 19 0 NA 0 NA (USDA, 
2018a) 
NA: not available  
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Major bioactive compounds 
Apart from providing various nutrients, mushrooms also contain many bioactive 
compounds that are highly related to many health benefits. Undigestible polysaccharides are 
probably the most well-known bioactive compound in mushrooms due to their antitumor and 
immunomodulatory activity (Valverde et al., 2015). Some mushroom polysaccharides such as 𝛽𝛽-
glucans have gone through clinical trials and have been used as cancer adjuvant therapy in Asian 
countries such as China for a long time (Valverde et al., 2015). Table 5 shows the 𝛽𝛽-glucan 
content in some commonly cultivated mushrooms. Phenolic compounds, another group of 
bioactive compounds in mushrooms, exhibited potential health benefits such as anti-allergic, 
anti-tumor, anti-inflammatory effects; most of these benefits are attributed to their excellent 
antioxidant activity (Cheung, Cheung, & Ooi, 2003; Kalač, 2016c; Valverde et al., 2015). Table 
6 shows the content of phenolic compounds in several most commonly cultivated edible 
mushrooms.  
Mushrooms also contain some unique proteins that possess a few health functions 
including anti-tumor, anti-bacterial, anti-fungal, and immunomodulatory activity  (Valverde et 
al., 2015). These proteins include lectins, fungal immunomodulatory proteins, ribosome 
inactivating proteins, antimicrobial proteins and laccases (X. Xu, Yan, Chen, & Zhang, 2011). A 
very special amino acid in mushrooms: L-ergothioneine has caught researchers’ attention for a 
long time due to its great antioxidant activity (Cheah & Halliwell, 2012; Feeney et al., 2014). L-
ergothioneine is a sulfur-containing amino acid that can be only synthesized in fungi, some 
cyanobacteria and mycobacteria (Genghof, 1970; Genghof & Van Damme, 1964; Pfeiffer, 
Bauer, Surek, Schömig, & Gründemann, 2011). Mushrooms as fungi are a good source of L-
ergothioneine; some species that contain high value of ergothioneine are king oyster mushroom, 
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maitake, and shiitake (N Joy Dubost, Beelman, Peterson, & Royse, 2006; Ey, Schömig, & 
Taubert, 2007). Its various roles include free radical scavanger, metal chelator, cytoprotective 
agent and immunomodulatory factor. Table 7 shows the ergothioneine content in some common 
edible mushrooms.  
Apart from the bioactive compounds listed above, there are also many others which catch 
scientists’ attention as well. These compounds include terpenoids, alkoloids such as eritadenine, 
lactones, nucleotide analogs, and polyketide such as lovastatin (Feeney et al., 2014; Kalač, 
2016c). 
In the following section, the health benefits of three representative bioactive compounds: 
beta-glucans, phenolic compounds and L-ergothioneine are going to be discussed in detail. 
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CHAPTER 3 
 
BETA-GLUCANS 
Structures and contents 
Polysaccharides in mushrooms are considered as a group of important bioactive 
compounds that possess many health benefits including anti-tumor, immune-modulatory, anti-
inflammation, anti-diabetic, anti-cholesterol effects, serving as prebiotics and so on (Feeney et 
al., 2014; Han et al., 2015; Jayachandran et al., 2017; Valverde et al., 2015). Although there are 
different polysaccharides in mushrooms including chitin, hemicellulose, mannans, alpha- and 
beta-glucans, galactans, and xylans, beta-glucans are the major polysaccharides in most 
mushrooms which consist half of the fungal cell wall mass and have been the most well studied 
for their immunomodulatory and anti-tumor activity (Borchers, Stern, Hackman, Keen, & 
Gershwin, 1999; Valverde et al., 2015; S. Wasser, 2002).  
The structures of beta-glucans from different sources such as cereals, yeast, bacteria and 
mushrooms are different. Beta-glucans found in cereals is a mixture of 𝛽𝛽(1,3) and 𝛽𝛽(1,4) 
glycosidic bonds (Figure 1) (Laroche & Michaud, 2007). However, beta-glucans found in some 
fungi and yeasts are composed of a 𝛽𝛽 (1,3) linked glucose backbone with 𝛽𝛽(1,6) linked glucose 
side chains (Figure 2) (Laroche & Michaud, 2007). Many mushroom species can produce 𝛽𝛽(1,3)-
D-glucans branched with 𝛽𝛽(1,6) linked side chains. The exact chemical structure such as 
branching degrees and molecular weight depend on the species of mushrooms, which could 
affect their predominant health benefits (Vannucci et al., 2013; F. Zhu, Du, Bian, & Xu, 2015). It 
has been found that beta-glucans derived from oat and barley are mainly responsible for lowering 
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blood cholesterol and sugar but mushroom derived beta-glucans are more responsible for anti-
tumor and immunomodulatory effect due to their particular structures (S. Wasser, 2002; F. Zhu 
et al., 2015).  
The amount of beta-glucans varies in different mushroom species and cultivars. Sari, 
Prange, Lelley, and Hambitzer (2017) analyzed the beta-glucan content in nine culinary and 
thirty wild mushrooms in Germany. Among nine culinary mushrooms,  Cantharellus cibarius 
(Chanterelle) contained more beta-glucans than others, with the mushroom cap having 
23.59g/100g dry matter (dm) and stipe having 26.93g/100g dm (Sari et al., 2017). However, 
Lentinula edodes and Pleurotus spp. also contained significant amount of beta-glucans, ranging 
from 15.32g/100g dm to 25.31g/100g dm. Comparatively, Agaricus bisporus has lower beta-
glucan content, which has around 9g/100g dm in the cap and around 10-12g/100g dm in the stipe 
Figure 1. 𝛽𝛽 − (1,4) -glucopyranosyl units with one  𝛽𝛽 −(1,3) 𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔𝑔 𝑔𝑔𝑔𝑔𝑢𝑢𝑢𝑢. Copyright 2007 Recent Patents 
on Biotechnology. (Laroche & Michaud, 2007)  
Figure 2. 𝛽𝛽 − (1,3)-D-glucans with 𝛽𝛽 − (1,6) linked side chains. 
Copyright 2007 Recent Patents on Biotechnology. (Laroche & 
Michaud, 2007) 
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(Sari et al., 2017). The thirty wild mushrooms were found to have variable amount of beta-
glucans but most of them, especially the bracket mushrooms, had higher amount of beta-glucans 
than Agaricus bisporus; Trametes versicolor (Turkey tail) had the highest beta-glucan content up 
to 60.79g/100g dm (Sari et al., 2017).  The analytic method they applied is currently the most 
reliable one developed by Megazyme © International Ireland Ltd, which is an enzyme-based 
assay kit that can measure the total glucans and alpha glucans; beta-glucans are then calculated 
by difference (Sari et al., 2017). This method is much more accurate compared with the phenol-
sulphuric-acid method, which is a commonly-used method for determining polysaccharides but 
cannot distinguish between alpha-glucans and beta-glucans (Sari et al., 2017). Bak, Park, Park, 
and Ka (2014) used the same assay kit to assess the beta-glucan content in fruiting bodies and 
mycelia in ten Lentinula edodes (Shiitake) cultivars in Korea. Their results showed that beta-
glucans ranged from  20.06 ± 1.76% to 44.21 ± 0.13% of mushroom dry weight in the pileus 
sections of the fruiting bodies, from 29.74 ± 1.40% to 56.47 ± 4.72% in the stipe sections and 
from 15.59 ± 5.96% to 27.09 ± 2.11% in mycelia (Bak et al., 2014). Many studies have found 
that those mushrooms that can be divided into cap (pileus) and stipe part usually have higher 
amount of beta-glucans in the stipes than caps (Bak et al., 2014; Sari et al., 2017). However, 
commercial mushrooms always have their stipes cut before sale, which could lead to a big loss of 
beta-glucans.  
Table 5 𝛽𝛽-glucan Content in Commonly Edible Mushrooms 
Scientific names Common names 𝛽𝛽-glucan (g/100g dry 
weight) 
Reference 
Agaricus bisporus (not specified) Button mushroom 2.60 (Nitschke et al., 2011) 
Agaricus bisporus (white) Button mushroom Cap: 8.608 Stalk: 
12.296 
(Sari et al., 2017) 
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Agaricus bisporus (brown) Button mushroom Cap: 8.837 Stalk: 
10.079 
(Sari et al., 2017) 
Lentinus edodes Shiitake 9.57 (Nitschke et al., 2011) 
 Cap: 
19.779 
Stalk: 
25.309 
(Sari et al., 2017) 
Pleurotus ostreatus Oyster mushroom 9.05 (Nitschke et al., 2011) 
24.231 (Sari et al., 2017) 
Pleurotus eryngii King oyster 
mushroom 
13.45 Nitschke et al. (2011) 
15.321 (Sari et al., 2017) 
Pleurotus citrinopileatus Golden oyster 
mushroom 
15.542 (Sari et al., 2017) 
Pleurotus pulmonarius Phoenix mushroom 17.466 (Sari et al., 2017) 
Pleurotus djamor Pink oyster 
mushroom 
21.703 (Sari et al., 2017) 
Flammulina velutipes Golden needle 
mushroom 
8.98 Nitschke et al. (2011) 
    
Table 6 Structural Features of Beta-glucans from Different Mushroom Species 
Scientific names Common names Name of beta-
glucans 
Structural features References 
Agaricus brasiliensis Himematsutake Beta-glucan 𝛽𝛽(1,3)-linked glucose 
backbone with a 
greater proportion of 
𝛽𝛽(1,6)-linked 
branching chains 
Camelini et al. 
(2005) 
Schizophyllum commune Common pelit 
gill 
Schizophyllan 𝛽𝛽(1,3)-linked glucose 
backbone with one 𝛽𝛽 
(1,6)-linked glucose 
residue every three 
residues 
F. Zhu et al. 
(2015) 
Lentinus edodes Shiitake Lentinan 𝛽𝛽(1,3)-linked glucose 
backbone with two 𝛽𝛽 
(1,6)-linked glucose 
side chains every five 
residues 
Schmid et al. 
(2001) 
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𝛽𝛽(1,3)-linked glucose 
backbone with two 
branch points every 
five residues; sides 
chains consist of both 
𝛽𝛽(1,6)-linked and 
𝛽𝛽(1,3)-linked glucose 
linkages 
(Sasaki & 
Takasuka, 1976) 
Pleurotus ostreatus Oyster 
mushroom 
Pleuran 𝛽𝛽(1,3)-linked glucose 
backbone with one 𝛽𝛽-
glucose residue linked 
by 𝛽𝛽 (1,6) linkages 
every four residues 
Karácsonyi and 
Kuniak (1994) 
Pleurotus eryngii King oyster 
mushroom 
𝛽𝛽-glucan 𝛽𝛽(1,3)-linked glucose 
backbone with 
substitution of single 
unit of glucose by 
𝛽𝛽(1,6) linkage on 
average to every three 
residues 
(Carbonero et al., 
2006) 
Grifola fondosa Maitake Grifolan 𝛽𝛽(1,3)-linked glucose 
backbone with single 
glucose unit linked by 
𝛽𝛽 (1,6) linkages every 
two residues 
Fang et al. (2012) 
Auricularia auricula Jaw’s ear 𝛽𝛽-glucan A main chain of 
𝛽𝛽(1,4) linked glucose 
residues with 
glucopyranosyl 
residue linked at O-6 
(70% ethanol/water 
solution extraction); 
A 𝛽𝛽(1,3)-linked 
backbone with two 𝛽𝛽-
glucose linked by 
𝛽𝛽(1,6) linkages every 
three residues (0.15M 
Ma, Wang, and 
Zhang (2008) 
 
 
 
 
 
S. Xu, Xu, and 
Zhang (2012) 
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aqueous NaCl 
extraction) 
 
 
 
Anti-tumor and immunomodulatory activity  
The interest of fungal 𝛽𝛽-glucans can be traced back to early 1990s. The first isolated 
beta-glucan containing product was zymosan from yeast cell walls, which could regulate the 
innate immune functions (Fizpatrick & DiCarlo, 1964; Pillemer & Ecker, 1941). Since that 
discovery, fungal beta-glucans have attracted scientists’ attention. The early research on anti-
tumor and immunomodulatory effect of mushroom beta-glucans focused on lentinan (from 
Lentinus edodes), schizophyllan (from Schizophyllum commune), PSK, Krestin (from Coriolus 
versicolor) and grifolan (from Grifola frondosa) (Borchers et al., 1999; Brown & Gordon, 2003; 
C.Ooi & Liu, 2000). Lentinan is probably one of the earliest well-studied edible mushroom 𝛽𝛽-
glucans since the other three are usually characterized as medicinal mushroom 𝛽𝛽-glucans. 
Chihara, Maeda, Hamuro, Sasaki, and Fukuoka (1969) isolated four polysaccharides from 
Lentinus edodes which included LC-33 (later known as lentinan), LC-1, EC-11 and EC-14 and 
tested their antitumor effect on mouse sarcoma 180. LC-11 and LC-33 showed great antitumor 
effect and the inhibitory ratio ranged from 73-100% (Chihara et al., 1969). Later more researches 
investigated the antitumor effect of lentinan on different tumor models such as MC-induced 
DBA/2.MC.CS-1 fibrosarcoma, gastric cancer, human colon carcinoma, oral squamous cell 
carcinoma, urothelial bladder cancer and so on (Harada, Itashiki, Takenawa, & Ueyama, 2010; 
Nakano et al., 1999; Ng & Yap, 2002; Suga, Shiio, Maeda, & Chihara, 1984; M. Sun, Zhao, Xie, 
Zhan, & Wu, 2015; L. Zhao, Xiao, & Xiao, 2013). There have been some clinical trials that 
tested the anti-tumor effect of lentinan in some patients but usually combined with chemotherapy 
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together (Oba, Kobayashi, Matsui, Kodera, & Sakamoto, 2009; Taguchi, 1987; P. Yang, Liang, 
Zhang, & Shen, 2008; S. Yoshino et al., 2000; Shigefumi Yoshino et al., 2010). The very first 
clinical trial was a four-year follow-up survey and randomized control trial on patients with 
advanced and recurrent stomach cancer to investigate the clinical efficacy when 
chemotherapeutic agent tegafur was combined with lentinan (Taguchi, 1987). The result showed 
significant increase of life span of the patients when lentinan was used together with the 
chemotherapy (Taguchi, 1987).   
Since the first study of lentinan, the research on mushroom 𝛽𝛽-glucans has been expanded 
to different mushrooms species such as  Ganoderma lucidum (reishi), Tremella fuciformis (snow 
fungus), Griflola frondosa (maitake), Hericium erinaceus (lion’s mane), Agaricus blazei Murrill, 
Flammulina velutipes (golden needle mushroom), Coriolus versicolor (turkey tail), Inonotus 
obliquus (chaga mushroom), and Pleurotus ostreatus (Oyster mushroom) (Meng, Liang, & Luo, 
2016). Among all these, Ganoderma lucidum is probably the most well-known medicinal 
mushroom for cancer treatment.  
Some recent anti-cancer studies of beta-glucans based on animal cancer models are 
available. For example, Hetland et al. (2016) studied the anti-tumor effect of mushroom extract 
Andosan ™ (82% mushroom extracts from Agaricus blazei Murill in which beta-glucans are the 
major compounds) in A/J Min/+ Mice, which is a mouse model for colorectal cancer. Their 
results suggested that the mice in the treatment group had significant lower number of 
adenocarcinomas in the intestine and 60% reduction in the tumor load; in addition, there was 
reduction of expression of legumain, which is a tumor-associated proteolytic enzymes that is 
linked with tumor invasion and metastasis and increased production of Th1 type cytokines 
(Hetland et al., 2016). They also found that Andosan™ had a significant cytotoxic effect on 
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human colon cancer cell line Caco-2 (Hetland et al., 2016). Another study conducted by Roldan‐
Deamicis, Alonso, Brie, Braico, and Balogh (2016) investigated the anti-cancer effect of 
Grifola frondosa (Maitake) extracts in BALBc mice that were implanted with murine tumor cells 
LM3 to induce breast cancer. Mice were divided into control group and two treatment groups; 
one treatment group fed with Maitake extract ProX4 (commercially Maitake extract containing 
30% of active proteo beta-glucan) and the other treatment group was fed with Maitake Standard 
(crude extract) (Roldan‐Deamicis et al., 2016). The treatments were done before the implantation 
of tumor cells to assess the preventive effect of Maitake extracts on oncogenesis. The results 
indicated that Maitake ProX4 could block more than 60% breast cancer development via 
blocking of tumor invasiveness and reduction of angiogenesis but Maitake Standard could only 
block 26% of cancer development (Roldan‐Deamicis et al., 2016).  
There are also a few recent studies based on human subjects. For example, a randomized 
clinical trial designed by Wang, Bi, Zou, and Gu (2012) studied the efficacy of a combination 
treatment with lentinan and chemotherapy to treat individuals with oesophageal carcinoma in 
which general condition, symptoms and signs, quality of life and clinical efficacy were assessed. 
Their results showed that patients receiving the combination therapy had significantly greater 
improvement in general condition, symptoms and signs and quality of life compared with the 
control after just one course of treatment; in addition, the clinical efficacy was significantly 
greater than the control after two courses of treatment (Wang et al., 2012). Moreover, the 
immune function was assessed through analysis of pro-inflammatory and anti-inflammatory 
cytokines. The results indicated increase of pro-inflammatory cytokines in serum including IL-2, 
IK-6 and IL-12 but decrease of anti-inflammatory cytokines including IL-4, IL5 and IL-10 in 
both groups, which indicated up-regulation of immune function; the changes in treatment group 
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were greater than those in the control group (Wang et al., 2012). Their study suggests that the 
combination of mushroom beta-glucans and traditional chemotherapy may enhance the treatment 
efficacy of cancer through improving patients’ immunity.  
Although there are extensive studies of the antitumor effect of 𝛽𝛽-glucans from different 
mushrooms, the use of mushroom 𝛽𝛽-glucans to treat cancers is still under research and 
development. In fact mushroom polysaccharides are commonly used as adjuvant cancer therapy 
in Asian countries such as China and Japan (C.Ooi & Liu, 2000; Meng et al., 2016). A few 
important mushroom antitumor polysaccharides that are commonly used in oriental medicine 
include lentinan from Lentinus edodes, schizophyllan from Schizophyllum commune, grifolan 
from Grifola frondosa,  PSK from Coriolus versicolor and polysaccharides from Ganoderma 
lucidum (C.Ooi & Liu, 2000; Meng et al., 2016). Nevertheless, they are still not widely used in 
Western medicine since the dose has not been standardized when used as cancer adjuvant 
therapy or as preventive functional food. In fact it is quite difficult to decide the suitable dose 
since different mushroom 𝛽𝛽-glucans have different anti-tumor effects, depending on their 
molecular weights, branching points, and confirmation (Borchers et al., 1999; Meng et al., 2016; 
F. Zhu et al., 2015). Therefore, more studies especially clinical trials are needed before 
mushroom 𝛽𝛽-glucans could be standardized as cancer therapy.  
Right after the discovery of the anti-tumor activity of 𝛽𝛽-glucans, scientists started to 
study the mechanisms of it, which lead to the discovery of another important health function of 
𝛽𝛽-glucans: immunomodulatory effect. The major role of 𝛽𝛽-glucans to inhibit the tumors is not a 
direct cytotoxic effect but to stimulate both the innate and adaptive immune systems and lead to 
a series of immune responses (Bohn & BeMiller, 1995). Innate immune system refers to the non-
specific immunity which includes a lot of leukocytes including neutrophils, macrophages, natural 
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killer cells, and dendritic cells. They usually act by recognition of pathogen associated patterns 
and then initiate a series of immune responses including phagocytosis, free radical production, 
cytokine production and presentation of antigens to lymphocytes (Volman, Ramakers, & Plat, 
2008). Adaptive immune system is more specific which involves production of antibodies by B 
lymphocytes to specific pathogens and attack of pathogen cells by cytotoxic and helper T cells 
(Volman et al., 2008). The antigen pieces presented by leukocytes and the cytokines produced by 
leukocytes are the activators of adaptive immunity (Volman et al., 2008).  
Since beta-glucans are the major components of cell walls in fungi, plants and some 
bacteria which are not present in humans, they are recognized by human immune system as 
pathogen-associated molecule patterns therefore can stimulate immune responses (Brown & 
Gordon, 2003; Janeway, 1992). It has been found that 𝛽𝛽-glucans activate immune cells such as 
macrophages, neutrophils, eosinophils, monocytes, dendritic cells and natural killer cells via 
immune cell receptors including CR3, lactosylceramide, scavenger receptors, Dectin-1 and TLR-
2/6 (Toll Like Receptors) (Brown & Gordon, 2003; Chan, Chan, & Sze, 2009).  Thornton, 
Vĕtvicka, Pitman, Goldman, and Ross (1996) studied sugar specificity for CR3 (CD11b/CD18) 
and found that CR3 could bind to pure beta-glucans from yeast, mushroom, seaweed or barley 
but also other molecules like  N-acetyl-D-glucosamine (NADG), alpha- or beta-
methylmannoside, and alpha- or beta-methyl-glucoside, which indicated that this receptor has a 
wide range of activators. However at least this study showed that CR3 (CD11b/CD18) is a 
leukocyte beta-glucan receptor which locates at the C-terminal to the I-domain of CD11b 
(Thornton et al., 1996). Later Dectin-1 was identified as a 𝛽𝛽-glucan receptor from screening of 
cDNA expression of macrophages with zymosan (yeast 𝛽𝛽-glucans) (Brown & Gordon, 2001). 
Dectin-1 is found to be expressed in populations of myeloid cells including monocytes, 
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macrophages, and neutrophil lineages; it is also expressed in dendritic cells and T cells (Taylor et 
al., 2002) . It has been shown that Dectin-1 activation collaborates with the induction of TLR2/6 
which together lead to the production of signaling molecules such as NF-𝜅𝜅B, signaling adaptor 
protein CARD9 and nuclear factor of activated T cells (NFAT) which further lead to the release 
of cytokines such as IL-12, IL-6, IL-10 and TNF-𝛼𝛼 (Brown & Gordon, 2003; Brown et al., 2003; 
Chan et al., 2009; Goodridge, Simmons, & Underhill, 2007; Gross et al., 2006; Rogers et al., 
2005). Some of these cytokines and singling pathways are very important immune responses to 
cancers. Because those studies which studied the collaborative response of dectin-1 and TLR 
used zymosan which is an extract from yeast cell wall and is not pure 𝛽𝛽-glucans, it was unclear 
the way that pure 𝛽𝛽-glucans interact with TLR (Chan et al., 2009). Moreover, because zymosan 
is not pure beta-glucans and even the beta-glucans contained inside is structurally very different 
from mushroom beta-glucans, the interactions happened between zymosan and Dectin-1 and 
TLR may not necessarily be the same between mushroom beta-glucans and these receptors. A 
few studies and reviews emphasized that the immunomodulatory effect of 𝛽𝛽-glucans is highly 
associated with their molecular weights, solubility, chemical modifications, branching points, 
polymer lengths and confirmations (Borchers, Keen, & Gershwin, 2004; Brown & Gordon, 
2003; Volman et al., 2008). Unfortunately there have not been too many studies that investigated 
the interaction between immune cell receptors and mushroom beta-glucans. However there are 
studies that measure changes of immune parameters when mushroom beta-glucans were used. 
Fruehauf, Bonnard, and Herberman (1982)’s research on lentinan is one of the earliest studies. 
They investigated the effect of lentinan on human monocytes and their results showed that 
lentinan increased production of IL-1 by K-562 cell line with only a very low concentration of 
0.1 𝜇𝜇g/ml (Fruehauf et al., 1982). Another early study was conducted by Herlyn, Kaneko, Powe, 
22 
 
Aoki, and Koprowski (1985), which is an in vivo study that studied the macrophage cytotoxicity 
affected by lentinan with the presence of antigen-specific monoclonal antibodies (MAbs). Their 
results showed that the murine peritoneal murine macrophages harvested after injection of 2.5 
mg/ per kg of body weight of lentinan possessed the best cytotoxic effect on human tumor cells 
including melanoma, colorectal carcinoma and pancreatic carcinoma with the presence of IgG1, 
IgG2a and IgG3 MAbs (Herlyn et al., 1985). Some early human clinical studies were also 
available. For example, Matsuoka, Seo, Wakasugi, Saito, and Tomoda (1997) conducted 
immunological analysis on patients with various advanced cancers with lentinan administration 
together with chemotherapy. They found that patients who responded to lentinan showed a great 
increase of killer T cell/suppressor T cell ratio [CD11(-) CD8(+)/CD11(+) CD8(+)] and decrease 
of production in IL-6, G-CSF and PGE2 which indicated an increase in immune potential 
(Matsuoka et al., 1997).  
The immunomodulatory effect of mushroom beta-glucans is still a popular research topic 
currently. Scientists are working on different mushroom species and the mechanisms of how 
mushroom beta-glucans mediate immune responses. Following are some recent studies within 
the latest 8 years.  
A study conducted by Yan et al. (2018) assessed the immunomodulatory effect of a novel 
polysaccharide AAMP-A70 which is a branched beta-glucan from Amillariella mellea and they 
found that this novel beta-glucan activated the mouse macrophage cells RAW264.7 via NF-
𝜅𝜅B/MAPK signalling pathway and TLR2 receptor and increased the secretion of NO, ROS, and 
TNF-𝛼𝛼, IL-6 and IL-1𝛽𝛽 phagocytosis (Yan et al., 2018). Similarly, Castro-Alves, Gomes, 
Menolli, Sforça, and Nascimento (2017) investigated the immunomodulatory effects of 
polysaccharide extracts from a commonly consumed mushroom Pleurotus albidus on murine 
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RAW 264.7 macrophages (Castro-Alves et al., 2017). They found that beta-glucans from this 
mushroom could stimulate the production of TNF-𝛼𝛼 and NO●, which are important marker for 
macrophage functions and signalling molecule involved in immune response respectively 
(Castro-Alves et al., 2017).  
Besides in vitro cell studies, animal model-based studies have been also conducted to 
show immunomodulatory effect of beta-glucans. For example, Masuda et al. (2013) assigned 
oral administration of beta-glucans from Grifola frondosa (Maitake) to colon- and mammary-
tumor-bearing mice to investigate if beta-glucans could initiate anti-cancer immunity. The results 
showed that beta-glucans from Maitake induced the maturation of dendritic cells via a C-type 
lectin receptor, which further induced the systemic tumor-antigen specific T cells; in addition, 
infiltration of the activated T cells into tumors was increased and the number of tumor-linked 
immunosuppressive elements was decreased (Masuda et al., 2013).  
Although most studies of beta-glucans are still based on in vitro cell cultures or in vivo 
animal models, there is still some evidence from human studies. Jesenak et al. (2013) designed a 
double-blind, placebo-controlled, randomized clinical trial to test immunomodulatory effect of 
pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections. 
The study found that the treatment group had significantly decreased number of flu- and flu-like 
disease and number of respiratory tract infections through the immunomodulation of both innate 
and adaptive immunity; the effect of pleuran to stimulate the humoral immune system was 
indicated by the increased production of three immunoglobulin isotypes, increased number of 
NK cells and slower decline of the number of T-cytotoxic lymphocytes (Jesenak et al., 2013). 
Another human clinical trial conducted by Bobovčák, Kuniaková, Gabriž, and Majtán (2010) 
studied the immunomodulatory effect of pleuran on cellular immune response in athletes after 1 
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hour of intensive exercise since excessive high-intensity exercise could suppress the immune 
system. The study found that the control group had 28% reduction of natural killer cell activity 
(NKCA) compared with the baseline value but the treatment group did not have significant 
reduction in NKCA, which suggested that pleuran can prevent immune suppression due to 
intensive exercise (Bobovčák et al., 2010). 
On the one hand, mushroom beta-glucans possess their immunomodulatory effects via 
immune-stimulation but on the other hand, they also present anti-inflammatory effect. 
Inflammation is the first reaction of human immune system to antigens, however, chronic 
inflammation is the major pathogenesis of autoimmune diseases and many chronic diseases such 
as diabetes, cancers, cardiovascular disease, neurological degeneration, inflammatory bowel 
disease and so on (Franceschi & Campisi, 2014). Chronic inflammation is characterized by 
persistent production of pro-inflammatory cytokines such as IL-6, IL-1𝛽𝛽 and TNF-𝛼𝛼 and 
dysregulation of cell signaling pathways (Du, Lin, Bian, & Xu, 2015; Franceschi & Campisi, 
2014).  
Wu et al. (2017) determined the in vitro anti-inflammatory activity of polysaccharide 
extracts from mycelia of Grifola frondosa in lipopolysaccharide (LPS)-induced inflammation in 
RAW 264.7 macrophage model. Their results showed that the high-pressure assisted 
polysaccharide extracts significantly inhibited the activation of NF-𝜅𝜅B and reduced the secretion 
of TNF-𝛼𝛼, IL-6 and IL-1𝛽𝛽 in LPS-stimulated macrophages (S. J. Wu et al., 2017). Another study 
conducted by Nishitani et al. (2013) investigated the anti-inflammatory effect of lentinan both in 
vitro and in vivo. Their results showed that lentinan significantly reduced IL-8 mRNA expression 
and NF-𝛼𝛼 activation in intestinal epithelial Caco-2 cells; in addition, lentinan also inhibited the 
expression of TNF receptor 1 (TNFR1) in Caco-cells in both protein and mRNA level (Nishitani 
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et al., 2013). In dextran sulfate sodium (DSS)-induced colitis mice, oral administration of 
lentinan to the mice showed the significant effect of amelioration on body weight loss, shorting 
of colon lengths, histological score and inflammatory mRNA expression in inflamed tissues 
(Nishitani et al., 2013). Moreover, lentinan inhibited the expression of TNFR1 in intestinal 
epithelial cells (Nishitani et al., 2013).  
Compared with the research on immune-stimulation, the number of researches on anti-
inflammation of mushroom beta-glucans is limited. More investigations are still necessary to 
understand the exact mechanisms of how beta-glucans could exhibit a balanced function between 
immune-stimulation and anti-inflammation. 
The anti-tumor and immunomodulatory of mushroom beta-glucans makes mushrooms a 
potential source to act as a cancer adjuvant therapy and immune booster. However there is still a 
long way to go to finalize the dose and potential risk of using mushroom beta-glucans as a cancer 
treatment or as a functional food since the difference in beta-glucans from different mushrooms 
heavily affect their biological effects and makes the interactions between beta-glucans and 
immune system even more complicated.  
 
Prebiotics 
A prebiotic is defined as “selectively fermented ingredients that allow specific changes, 
both in the composition and/or activity in the gastrointestinal microbiota that confers benefits 
upon host well-being and health” (Gibson, Probert, Van Loo, Rastall, & Roberfroid, 2004). A 
similar term ‘probiotics’ on the other hand refers to the “preparations of or products containing 
viable, defined microorganisms in sufficient numbers, which alter the microflora (by 
implantation or colonization) in a compartment of the host and by that exert beneficial health 
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effects in this host” (Schrezenmeir & de Vrese, 2001). In simple words, prebiotics are the ‘food’ 
of probiotics. A positive effect of prebiotics is to change the gut microbiota composition in the 
way that support the growth of probiotics such as bifidobacterial and lactobacilli which inhibit 
the growth of undesired bacteria, lower the incidence of infection, improve colonic integrity and 
enhance host immunity (Douglas & Sanders, 2008; G. T. Macfarlane, Steed, & Macfarlane, 
2008; Palframan, Gibson, & Rastall, 2003). Gut microbiota is not only important for gut health 
but is also associated with several metabolic dysregulations, which could lead to inflammatory 
diseases such as diabetes, obesity and cancer (Jayachandran et al., 2017). It has been show that 
gut microbiota is essential to regulate immune homeostasis in the host, which affect both the 
innate and adaptive immunity (H.-J. Wu & Wu, 2012). Alternations of gut microbiota could lead 
to autoimmune diseases due to the dysregulation of the immune system (H.-J. Wu & Wu, 2012). 
Some well-studied and commercialized prebiotics include inulin, fructo-oligosaccharides, 
galacto-oligosaccharides, soya-oligosaccharides, xylo-oligosaccharides, isomalto-
oligosaccharides, lactulose, and polydextrose (Alander et al., 2001; Crittenden & Playne, 2002; 
Hayakawa et al., 1990; Kaneko, Yokoyama, & Suzuki, 1995; Losada & Olleros, 2002; S. 
Macfarlane, Macfarlane, & Cummings, 2006; Roberfroid, 2007).  
Apart from the non-digestible oligosaccharides, non-digestible long polysaccharides have 
been attracting scientists’ interests as a potential new source of prebiotics (Lam & Chi-Keung 
Cheung, 2013). Beta-glucans, as one type of non-digestible polysaccharides which are the major 
cell components in plants and fungi have been suggested as a good source of prebiotics  (Lam & 
Chi-Keung Cheung, 2013). Starting from later 1990s and early 2000s, research on beta-glucans 
as prebiotics to promote growth of bifidobacterial and lactobacilli has been continuously 
conducted but early research is on cereal beta-glucans such as oat and barley (Dongowski, Huth, 
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Gebhardt, & Flamme, 2002; Drzikova, Dongowski, & Gebhardt, 2005; Jaskari et al., 1998; 
Kontula, von Wright, & Mattila-Sandholm, 1998). However besides cereals, mushrooms are also 
considered as a good source of beta-glucans and have a great potential to serve as prebiotics 
since their world production is huge and still keeps increasing (Kalač, 2016a). Until 2009, there 
was first research that studied the potential prebiotic activity of extracts from Pleurotus ostreaus 
and Pleurotus eryngii which contain both alpha-glucans and beta-glucans using nine strains of 
Lactobacillus, Bifidobacterium and Enterococcus (Synytsya et al., 2009). Their results showed 
that the extracts from both Pleurotus mushrooms supported the growth of Lactobacillus strains 
but Pleurotus eryngii favored the growth more than Pleurotus ostreaus; strain Bifi A and B 
utilized the mushroom extracts very differently, with Bifi A using Pleurotus ostreaus better than 
Pleurotus eryngii but with Bifi B only using Pleurotus eryngii; Enteroccocus strains could utilize 
both mushroom extracts but their growth rate was slower than Lactobacillus (Synytsya et al., 
2009). These results suggested that different probiotic bacteria are selective about mushroom 
glucan sources with certain strains preferring certain chemical structures (Synytsya et al., 2009). 
This is an important implication when selecting mushroom beta-glucans as good prebiotic 
sources.  
The number of researches about mushroom beta-glucans as a potential prebiotic source is 
still increasing. J. Zhao and Cheung (2011) showed that beta-glucans from different sources such 
as seaweed, barley and mushrooms can promote the growth of Bifidobacterium 
infantis, Bifidobacterium longum, and Bifidobacterium; the populations of three bacteria all 
increased in a large number. Among the three bacteria, B. infantis produced almost double the 
amount of short-chain fatty acids compared to the other two (J. Zhao & Cheung, 2011). Chou, 
Sheih, and Fang Tony (2013) not only studied the effect of mushroom polysaccharides on 
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bacterial growth in petri dish but also in simulated digestive environment. They found that low 
concentration of polysaccharides (0.1% - 0.5%) derived from the stipes of three mushroom 
species: Lentinula edodes, Pleurotus eryngii, and Flammulina velutipes can enhance the viability 
of Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium longum subsp. longum 
during cold storage; in addition, significant protective effects of polysaccharides from these three 
mushrooms on probiotics were found in a simulated environment of gastric juice and bile acid. 
Similarly, another study conducted by Nowak, Nowacka-Jechalke, Juda, and Malm (2017) also 
supports the finding that fungal polysaccharides can stimulate growth of prebiotics. They 
investigated the effect of polysaccharides derived from various wild mushroom species in Poland 
on the growth of Lactobacillus acidophilus and two stains of Lactobacillus rhamnosus; 
moreover, they also studied the bioavailability of the polysaccharides in artificial human gastric 
juice by calculating the degree of hydrolysis (Nowak et al., 2017). Their results indicated that 
mushroom polysaccharides stimulated the growth of Lactobacillus acidophilus and two stains of 
Lactobacillus rhamnosus, with some mushroom species significantly increasing the metabolism 
of glucose in the bacteria (Nowak et al., 2017). The bioavailability study showed that 
polysaccharides in mushrooms were highly resistant to acidity, which means that they could 
reach the colon where the probiotic bacteria are abundant (Nowak et al., 2017).  
Besides bacteria culture study, there are some research carried out in animal models to 
study the beneficial effect of mushroom polysaccharides on gut health. Varshney et al. (2013) 
conducted an animal study by feeding the mice with either white-button mushroom diet or 
control diet for six weeks and checked the gut microbiota, urinary metabolome and resistance to 
gastrointestinal pathogens. What they found were that white-button mushroom diet changed the 
composition of the gut microbiota by increasing Bacteroidetes phylum and decreasing Firmicutes 
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phylum; in addition, mice that were introduced to Citrobacter rodentium infection had fewer 
inflammatory cells and less severe colitis in the GI mucosa when they were fed with white-
button mushroom diet (Varshney et al., 2013). Another recent esearch conducted by Ren et al. 
(2018) investigated the potential of polysaccharides extract from Hericium erinaceus (Lion’s 
Mane) to treat and prevent inflammatory bowel disease by testing its anti-inflammatory effect in 
C57BL/6 mice with dextran sulfate sodium (DSS) -induced colitis. Hericium ernaceus is a very 
valuable edible and medicinal mushroom commonly consumed in China. The results showed that 
polysaccharides from Hericium erinaceus can down regulate many key markers of oxidative 
stress including nitric oxide (NO), malondialdehyde (MDA), total superoxide dismutase (T-
SOD), and myeloperoxidase (MPO) (Ren et al., 2018). In addition, it also suppressed the 
secretion of inflammatory molecules such as interleukin (IL)-6, interleukin (IL)-1β, tumor 
necrosis factor (TNF)-α, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) 
(Ren et al., 2018). The examination of the gut microbiota showed that the DSS-induced gut 
dysbiosis was reversed by the polysaccharides (Ren et al., 2018). This research demonstrates that 
polysaccharides from Hericium erinaceus exhibit great potential to ameliorate the inflammatory 
bowel disease by regulating the gut microbiota and reducing the clinical symptoms caused by 
inflammation.   
So far the studies that only investigate the effect of pure mushroom beta-glucans as a 
prebiotic are still limited since most studies that looked at the mixture of polysaccharides. 
Moreover, more human studies are needed since the utilization of beta-glucans by probiotics 
could be very different in vivo since human gut environment is very complicated. The 
bioavailability of mushroom beta-glucans in human gut and the exact mechanism of how 
mushroom beta-glucans could benefit the gut heath are two possible future research directions. 
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CHAPTER 4 
 
PHENOLIC COMPOUNDS 
Types and contents 
Phenolic compounds from different sources such as grains, vegetables, fruits, wine, and 
mushrooms have been extensively studied by scientists due to their strong antioxidant activity 
(Adom & Liu, 2002; Frankel, Waterhouse, & Teissedre, 1995; Kähkönen et al., 1999; Rice-
Evans, Miller, & Paganga, 1997; J. Sun, Chu, Wu, & Liu, 2002). Phenolic compounds in edible 
mushrooms have been studied since 2003. Cheung et al. (2003) investigated the antioxidant 
capacity of phenolic compounds in water extracts and methanol extracts from Lentinus edodes 
and Volvariella volvacea. Later more mushroom species including cultivated mushrooms such as 
Agaricus bisporus, Pleurotus ostreatus, Flammulina velutipes and Auricularia auricula-judae 
and a large number of wild edible mushrooms had their phenolic contents and antioxidant 
activity determined (N. Joy Dubost, Ou, & Beelman, 2007; Palacios et al., 2011; Reis, Martins, 
Barros, & Ferreira, 2012; Wong & Chye, 2009).  
The major phenolic compounds found in mushrooms are phenolic acids which can be 
divided into two groups, hydroxybenzoic acid and hydroxycinnamic acid (Ferreira, Barros, & 
Abreu, 2009). Hydroxybenzoic acids found in mushrooms include p-hydroxybenzoic, 
protocatechuic, gallic, gentisic, homogentisic, vannilic, 5-sulphosalicylic, syringic, veratric and 
vanillin (Ferreira et al., 2009). Hydroxycinnamic acids commonly reported in mushrooms 
include p-coumaric, o-coumaric, caffeic, ferulic, sinapic, 3-o-caffeoylquinic, 4-o-caffeoylquinic, 
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and 5-o-caffeoylquinic (Ferreira et al., 2009). Phenolic acids are usually present in bound forms 
through glycosidic bonds with simple sugars and polysaccharides in cell wall structure or 
through ester bonds with organic acids (Kozarski et al., 2015). Flavonoids are the second most 
abundant phenolic compounds in mushrooms; myricetin, chrysin, catechin, hesperetin, quercetin, 
rutin, and kaempferol have been found in mushrooms (Ferreira et al., 2009).  
A few research studies the phenolic compounds in edible mushrooms from different 
countries. Islam, Yu, and Xu (2016) assessed the total phenolic content (TPC), total flavonoid 
content (TFC) and free phenolic acid content in 43 commonly consumed mushroom in China. 
The TPC ranged from 0.19 to 26.21 mg GAE/g dry weight (DW) with big variations between 
different species;  among all mushroom species, stone ear (26.21mg GAE/g DW), porcino nero 
(11.94 mg GAE/g DW) and yellow bolete (10.62 mg GAE/g DW) had the highest TPC (Islam et 
al., 2016).  The TFC ranged from 0.05 to 5.90 mg CAE/g, with pine spike (5.90 mg CAE/g DW), 
coral mushroom (3.65 mg CAE/g DW), nameko (3.00 mg CAE/g DW), jersey cow mushroom 
(2.18 mg CAE/g DW), yellow bolete (2.15 mg CAE/g DW), wild porcino nero (2.13 mg CAE/g 
DW) and stone ear (2.09 mg CAE/g DW) having relatively high TFC content (Islam et al., 
2016). Free phenolic acids were assessed using HPLC UV-DAD and the results showed that 
gallic acid was the most abundant phenolic acid that were detected in most mushroom species, 
with princess matsutake having the highest content (1376.79 𝜇𝜇g/g DW) (Islam et al., 2016). 
Other free phenolic acids found in some of the 43 mushroom species included gentisic acid,  p-
hydroxybenzoic acid, 2,3,4-hydroxubenzoic acid, 3,4-dihydroxybenzaldehyde, vanillic acid, 
caffeic acid, and p-comaric acid (Islam et al., 2016). Kaewnarin, Suwannarach, Kumla, and 
Lumyong (2016) determined the phenolic content, flavonoid content and phenolic profiles of 
four wild edible mushroom species in Thailand by using four different extraction solvents. What 
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they found was that water was particularly efficient for extraction of phenolics of these four 
mushroom species (Kaewnarin et al., 2016). The total phenolic compounds ranged from 2.13 to 
20.2 mg GAE/g DW with Russula emetica having the highest total phenolic content in water 
extract (20.2 mg GAE/g DW) (Kaewnarin et al., 2016). The total flavonoid content ranged from 
0.03 to 0.98 mg QE/g DW (mg quercetin equivalent/g DW), with Rugiboletus extremiorientalis 
having the highest total flavonoid content in methanolic extract (0.98 mg QE/g DW) (Kaewnarin 
et al., 2016). The HPLC analysis of phenolic compounds found 8 phenolic acids (gallic acid, 
protocatechuic acid, vanillic acid, syringic acid, sinapic acid, ferulic acid, m-courmaric acid, 
rosmarinic acid) and 4 flavonoid compounds (catechin, rutin, quercetin, apigenin) with some 
only appearing in one mushroom species (Kaewnarin et al., 2016). Gallic acid and 
protocatechuic acid were detected in all mushrooms; highest content of gallic acid and 
protocatechuic acid were found in the water extract of Rugiboletus extremiorientalis (36.545 
𝜇𝜇g/g DW and 31.017 𝜇𝜇g/g DW respectively) (Kaewnarin et al., 2016). Another study conducted 
by Yahia, Gutiérrez-Orozco, and Moreno-Pérez (2017) identified the phenolic compounds in 
seventeen wild mushrooms including nine edible mushroom species in Central Mexico. The total 
soluble phenols in nine edible mushrooms ranged from 36.44 to 120.98 mg GAE/100g fresh 
weight (FW) with Boletus luridus having the highest amount (Yahia et al., 2017). The total 
flavonoid content ranged from 7.09 to 34.57 mg CAE/100mg FW with Ramaria flava having the 
highest content (Yahia et al., 2017). HPLC analysis of phenolic compounds detected nine 
phenolic acids in edible mushrooms including p-hydroxybenzoic acid, o-courmaric acid, 
chlorogenic acid, protocatechuic acid, caffeic acid, cinnamic acid, sinapic acid, ferulic acid, and 
vanillic acid; R. flava had highest content of sinapic acid (36.706 mg/100g DW) and A. 
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pantherina had the highest content of p-hydroxybenzoic acid (36.403 mg/100g DW) (Yahia et 
al., 2017).  
However these studies may underestimate the total phenolic content and total phenolic 
acids in mushrooms since many phenolic acids exist in insoluble bound forms but the extraction 
methods in these studies could only extract the soluble phenolic compounds. Furthermore, the 
extraction solvents can affect the extraction efficiency but solvents used in these studies were all 
different, which makes the comparison of different mushroom species difficult. It is very 
important to develop consistent extraction methods that extract both soluble free and insoluble 
bound phenolic compounds in the future study, which could make the data more reliable and 
easier to be compared. 
 
Table 7 Contents of Phenolic Compounds in Some Commonly Cultivated Mushrooms  
Scientific names Common names Phenolic 
compounds 
(mg/GAE/g DW) 
Sample 
origin 
Reference 
Agaricus bisporus Button 
mushroom 
3.748 China (Guo et al., 2012) 
8 U.S. (N. Joy Dubost et al., 2007) 
Agaricus blazei Sun mushroom 8.348 China (Guo et al., 2012) 
Lentinus edodes Shiitake 4.294 China (Guo et al., 2012) 
6.27 Taiwan, 
China 
(J.-H. Yang, Lin, & Mau, 2002) 
4.32 U.S. (N. Joy Dubost et al., 2007) 
36.19 Denmark (Boonsong, Klaypradit, & 
Wilaipun, 2016) 24.25 
10.46 
Pleurotus eryngii King oyster 
mushroom 
3.171 China (Guo et al., 2012) 
1.42 Turkey (Oke & Aslim, 2011) 
0.93  
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Pleurotus ostreatus Oyster 
mushroom 
4.002 China (Guo et al., 2012) 
15.7 Taiwan, 
China 
(J.-H. Yang et al., 2002) 
4.27 U.S. (N. Joy Dubost et al., 2007) 
Flammulina 
velutipes 
Golden needle 
mushroom 
3.459 China (Guo et al., 2012) 
White: 8.38 
Yellow: 9.26 
Taiwan, 
China 
(J.-H. Yang et al., 2002) 
Volvariella 
volvacea 
 13.914 China (Guo et al., 2012) 
Straw 
mushroom 
22.97 Denmark (Boonsong et al., 2016) 
27.89 
1.99 
Auricularia 
auricula 
Jaw’s ear 4.000 China (Guo et al., 2012) 
13.61 Turkey (Oke & Aslim, 2011) 
10.54 
2.90 Denmark (Boonsong et al., 2016) 
2.75 
2.17 
Auricularia 
polytricha 
 
Wood ear 3.105 China (Guo et al., 2012) 
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Table 8 Major Phenolic Compounds (𝜇𝜇g/g DW) in Some Commonly Cultivated Mushrooms Scientific names Common names 1 2 3 4 5 6 7  8 9 10 11 12 13 14 15 Reference 
Agaricus 
bisporus Button mushroom 15.5 0.5 63.7 10.4 16.4 94.9 15.4 3444.3 22.4 16.2 n.d, 258.7 NA NA NA Palacios et al. (2011) n.d. n.d. n.d. n.d. n.d. 16 n.d. n.d. 19 32 n.d. 464 13 NA NA (Kim et al., 2008) 
Pleurotus 
ostreatus Oyster mushroom n.d n.d. n.d. 11.5 20.16 290.34 4.69 629.86 21.99 19.32 292.62 n.d. NA NA NA (Palacios et al., 2011) n.d. n.d. 19 n.d. n.d. 7 n.d. 16 21 18 n.d. n.d. 9 NA NA (Kim et al., 2008) 
Lentinus 
edodes Shiitake n.d. 3 n.d. n.d. n.d. 21 n.d. n.d. n.d. 16 n.d. n.d. n.d. NA NA (Kim et al., 2008) 
Pleurotus 
eryngii King oyster mushroom 
n.d. n.d. n.d. n.d. n.d. 5 n.d. n.d. n.d. n.d. n.d. n.d. 8 NA NA (Kim et al., 2008) n.d. 32 n.d. n.d. 6 n.d. 138 NA NA NA NA NA NA 10 n.d. (Oke & Aslim, 2011) 10 n.d. n.d. 4 n.d. 450 420 NA NA NA NA NA NA 12 n.d. (Oke & Aslim, 2011) 
Flammulina 
velutipes Golden needle mushroom 
17 n.d. 26 n.d. 9 21 n.d. 15 n.d. 21 n.d. 15 n.d. NA NA (Kim et al., 2008) 
Auricularia 
auricula 
Jaw’s ear 76 NA 314 12 n.d. 636 488 NA NA NA NA NA NA 104 254 (Oke & Aslim, 2011) 
36 
 
200 NA 360 n.d. n.d. 360 700 NA NA NA NA NA NA 140 100 (Oke & Aslim, 2011) 
1 Caffeic acid; 2 Catechin; 3 Catechin; 4 p-courmaric acid; 5 Ferulic acid; 6 Ferulic acid; 7 Ferulic acid; 8 Homogentisic acid; 9 Myricetin; 10 Protocatechuic 
acid; 11 Gentisic acid; 12 Pyrogallol; 13 Naringin; 14 Syringic acid; 15 Sinapinic acid 
n.d.: not detected; NA: not available 
 
Antioxidant activity  
Free radicals are generated in many metabolic processes especially in cell respiration and immune response (Kozarski et al., 
2015). Apart from endogenous generation of free radicals, there are also many external sources of free radicals including UV light, 
environmental toxins, ionizing radiation and so on (Kozarski et al., 2015). High amount of free radicals increase the oxidative stress in 
human bodies, which damages the tissues and contributes to many chronic diseases including cancer, cardiovascular disease, diabetes, 
neurodegenerative diseases (Santilli, D'Ardes, & Davì, 2015; Valverde et al., 2015). Although humans have endogenous antioxidant 
defense mechanism, imbalanced diet and unhealthy life style could lead to elevated oxidative stress which disrupt the antioxidant 
hemostasis in the body. Mushrooms have caught many researchers’ attention due to their great nutritional values and high content of 
antioxidant compounds especially phenolic compounds (Kozarski et al., 2015). Phenolic compounds regulate the oxidative stress 
either through direct actions such as scavenging the free radicals, quenching singlet oxygen, chelating metals, and regenerating other 
antioxidants or through indirect regulations of the endogenous antioxidant defense mechanism via interactions with enzymes and cell 
receptors in different signaling pathways (Kozarski et al., 2015).  
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There are many studies of phenolic compounds and their antioxidant activity in different 
species of mushrooms. Islam et al. (2016) assessed the antioxidant activity of the phenolic 
compounds in 43 commonly consumed mushrooms in China. Different antioxidant assays 
showed varied antioxidant activities in different mushrooms, with highest DPPH value in 
porcino nero, highest FRAP value in mulberry yellow, highest ABTS value in stone ear and 
highest MCA value in Maitake (Islam et al., 2016). Another study conducted by Palacios et al. 
(2011) determined the phenolic contents and their antioxidant activities in eight cultivated and 
wild edible mushrooms commonly consumed in Spain. The antioxidant activity was assessed by 
monitoring inhibition of ABAP-induced lipid peroxidation (Palacios et al., 2011). The assay 
found that all mushrooms exhibited inhibitory effect but the inhibition did not correlate with total 
phenolic content nor flavonoid content (Palacios et al., 2011). Furthermore, it also did not 
correlate with the amount of homogenetisic acid which was the most abundant phenolic acid in 
these mushrooms (Palacios et al., 2011). They concluded that each phenolic compound or each 
group of compounds may exhibit different antioxidant activities, with some having much 
stronger activity than others (Palacios et al., 2011). Similarly, Kaewnarin et al. (2016) assessed 
the antioxidant activities of the phenolic compounds in four popular wild edible mushrooms in 
Thailand using  DPPH assay, ABTS assay and FRAP assay. They found that antioxidant 
activities of phenolic compounds largely depended on mushrooms species, extraction methods 
and assay methods (Kaewnarin et al., 2016). Significant correlation was found between phenolic 
content and ABTS assay. There are more researches regarding the phenolic compounds and their 
antioxidant activities in edible mushrooms all around the world including Poland, Turkey, 
Ethiopia, Mexico, Bangladesh and so on (Chowdhury, Kubra, & Ahmed, 2015; Orhan & Üstün, 
38 
 
2011; Özyürek, Bener, Güçlü, & Apak, 2014; Radzki, Slawinska, Jablonska-Rys, & Gustaw, 
2014; Woldegiorgis, Abate, Haki, & Ziegler, 2014).  
While a lot of studies assessed the antioxidant activity of phenolic compounds in 
mushrooms and provided strong evidence to support the antioxidant activity, their results were 
not very reliable due to their chemical assessing methods. DPPH, ABTS and FRAP methods 
were applied to determine the antioxidant activity but these methods have disadvantages and 
cannot provide accurate results (Amorati & Valgimigli, 2015). DPPH• is a highly persistent 
radical which can be reduced to DPPHH by a reductant; due to the similar electronic 
configuration between DPPH• and peroxyl radicals, the rate constant between DPPH• and 
phenolic antioxidants and the rate constant between ROO• and phenolic antioxidants have the 
same ranking (Amorati & Valgimigli, 2015). However the linear relationship between rate 
constants of DPPH• and ROO• can be only maintained in aprotic solvents while most studies 
used polar protic solvents such as ethanol and methanol; these solvents can make the reaction 
between DPPH• and phenols much faster (Amorati & Valgimigli, 2015). ABTS+• is a radical 
cation used in TEAC test (Trolox-Equivalent Antioxidant Capacity). The limitation of this test is 
that the reaction between antioxidants and ABTS+• uses the electron transfer mechanism but the 
reaction between antioxidants and peroxyl radicals uses the H-atom transfer (Amorati & 
Valgimigli, 2015). Both DPPH• and ABTS+• are used as radical probes in the antioxidant test 
but they are chemically different from the radicals responsible for the autooxidation in the real 
systems; these radical may be reduced by any reductant that may have no antioxidant activity 
therefore these methods can only indicate the reducing power but not the antioxidant activity 
(Amorati & Valgimigli, 2015). FRAP also has its limitation that the unpaired electrons in d-f 
orbitals and the reactivity of the inorganic Fe3+ cannot represent the characteristics of organic 
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peroxyl radicals (Amorati & Valgimigli, 2015). While TOSC assay is a good method to assess 
the antioxidant activity which can avoid the interference of the colored matrices, no research 
above used this assay (Amorati & Valgimigli, 2015). In conclusion, the above chemical assays 
cannot provide unbiased and accurate results of the antioxidant activity of the phenolic 
compounds. 
Although there is a lack of reliable results from good chemical assays of the antioxidant 
activity of mushrooms, there are still a few in vivo animal studies that provide some evidence. 
Jun Liu, Jia, Kan, and Jin (2013) studied on the antioxidant activity of the phenolic compounds 
in white button mushroom in mice. They measured the concentration of antioxidant enzymes 
including SOD, GSH-Px and CAT in serums, livers and hearts in 30 mice that were divided into 
five different groups (Jun Liu et al., 2013). The results indicated that ethanolic extract at the dose 
of 600 and 1200 mg/kg body weight treatment had the antioxidant enzymes significantly 
increase in serums, liver and hearts compared with the normal control group (Jun Liu et al., 
2013). The possible mechanism of the increased antioxidant enzymes is due to the enhanced 
mRNA expression of these enzymes by phenolic compounds (Jun Liu et al., 2013). Another 
study conducted by Khalili, Ebrahimzadeh, and Kosaryan (2015) assessed the iron-chelating 
activity of the phenolic compounds from the Angel’s Wings mushroom (Pleurotus porrigens) in 
iron-overloaded mice. The results indicated a significant decrease of plasma iron concentration 
and a remarkable reduction in the extent of necrotic hepatocytes, fibrous tissues and pseudo-
lobules in the livers of mice in the treatment group (Khalili et al., 2015).  
The antioxidant activity of phenolic compounds is well proved in fruits, grains and 
vegetables, there is also a great potential for phenols in mushrooms to exhibit antioxidant activity 
(Adom & Liu, 2002; Chu, Sun, Wu, & Liu, 2002; J. Sun et al., 2002). However it is very 
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necessary for researchers to choose suitable chemical assays such as TOSC that could provide 
unbiased results. Also more in vivo studies are necessary to evaluate the antioxidant activity of 
mushrooms in complex living systems and find out the mechanisms behind.  
 
Antimicrobial activity 
Phenolic compounds have been investigated for their preventive effects against chronic 
diseases over the past 20 years (Daglia, 2012). In recent years, the antimicrobial activity of 
phenolic compounds has attracted scientists’ attention because of their potential to become new 
antimicrobial agents since antibiotic resistance of microbials has been a big problem (Daglia, 
2012). Mushrooms are a good sources of phenolic compounds especially phenolic acids and 
haven shown antimicrobial activity against several bacteria (Alves et al., 2013; Chowdhury et al., 
2015; Nowacka et al., 2014, 2015; Smolskaitė, Venskutonis, & Talou, 2015).  
Nowacka et al. (2014) studied the antibacterial activity of the phenolic extracts from 19 
wild edible mushrooms in Poland. They assessed the minimal inhibitory concentration (MIC) of 
the phenolic extracts to inhibit the growth of four gram-positive (Staphylococcus epidermidis, 
Staphylococcus aureus, Bacillus subtilis, Micrococcus luteus) and four gram-negative bacteria 
(Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis). What 
they found is that the phenolic extracts from 19 mushrooms exhibit moderate antimicrobial 
activity against both gram-positive and gram-negative bacteria; Micrococcus luteus, Bacillus 
subtilis and Pseudomonas aeruginosa were relatively susceptible to the phenolic extracts from 
mushrooms while Proteus mirabilis, Klebsiella pneumoniae and Staphylococcus aureus were 
less sensitive to the extracts (Nowacka et al., 2014). Another study which was also conducted by 
Nowacka et al. (2015) further studied the antimicrobial activity of phenolic extracts in 31 wild 
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mushroom species in Poland. The bacteria strains used were the same as the above study. The 
antibacterial assay showed that the phenolic extracts in the 31 mushroom species can inhibit both 
gram-positive and gram-negative bacteria with the inhibitory activity against gram-positive 
bacteria slightly higher than gram-negative bacteria (Nowacka et al., 2015). The bacteria strains 
that were more susceptible to the phenolic extracts were the same as the previous study which 
included Micrococcus luteus, Bacillus subtilis and Pseudomonas aeruginosa (Nowacka et al., 
2015). Proteus mirabilis were found to be the least susceptible to the mushroom phenolic 
extracts (Nowacka et al., 2015).  Although these two studies assessed the antibacterial activity of 
a large number of mushroom species, they have not investigated the specific antimicrobial 
activity of different phenolic compounds from mushrooms separately. Alves et al. (2013) did 
take a further step to investigate the antimicrobial activity of 14 phenolic acids commonly 
identified in wild mushrooms against six gram-positive bacteria (methicillin-susceptible 
Staphylococcus aureus, methicillin-resistant Staphylococcus aureus,  Staphylococcus 
epidermidis, Enterococcus faecalis and Listeria monocytogenes) and five gram-negative bacteria 
(Escherichia coli, Proteus mirabilis and Morganella morganii, Pasteurella multocida and 
Neisseria gonorrhoeae). Their results indicated that 2,4-dihydroxybenzoic acid, protocatechuic 
acid, vanillic and p-coumaric acid showed greater antimicrobial activity against both gram-
positive and gram-negative bacteria (Alves et al., 2013). They also found that cinammic acid 
derivatives had better antimicrobial activity against cocci bacteria (Alves et al., 2013). The 
structure-activity relationship analysis further showed that the presence of carboxylic acid, two 
hydroxyl groups in para and ortho positions of the benzene ring and a methoxyl group in the 
meta position is important for the antimicrobial activity against methicillin-resistant 
Staphylococcus aureus (Alves et al., 2013). 
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The most antimicrobial studies were conducted in vitro and there is a lack of evidence in vivo. 
Therefore it is very necessary to conduct both animal study and human clinical trials in the 
future.  
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CHAPTER 5 
 
L-ERGOTHIONEINE 
Background 
L-ergothioneine is a naturally amino acid derivative from histidine with methionine 
providing the methyl group and cysteine providing sulfur group (Fig. 3) (Donald B Melville, 
Eich, & Ludwig, 1957). It was first discovered by Charles Tanret when he was investigating the 
ergot fungus Claviceps purpurea (Tanret, 1909). Ergothioneine can be only synthesized by non-
yeast fungi, some cyanobacteria and mycobacteria (Genghof, 1970; Genghof & Van Damme, 
1964; Donald B. Melville, 1959; Pfeiffer, Bauer, Surek, Schömig, & Gründemann, 2011). 
Although animals are not able to synthesize ergothioneine, it is widely distributed in various 
cells and tissues, especially those that are usually exposed to high oxidative stress and 
inflammation such as erythrocytes, bone marrow, liver, kidney, semen and eyes (Cheah & 
Halliwell, 2012; Kalaras, Richie, Calcagnotto, & Beelman, 2017; Leone & Mann, 1951; Shires, 
Brummel, Pulido, & Stegink, 1997). Ergothioneine cannot cross the cell membrane directly, it 
needs to be transported through a transmembrane transporter protein OCTN1 encoded by gene 
SLC22A4 (Gründemann et al., 2005). Studies showed high expression of OCTN1 mRNA in 
kidney, ileum, bone marrow, cerebellum, spinal cord, coronary artery endothelium, lung, trachea, 
peripheral blood monocytes, macrophages, CD14+ cells, and synovia (Gründemann et al., 2005; 
Taubert, Jung, Goeser, & Schömig, 2009; X. Wu et al., 2000). High accumulation of 
ergothioneine and high expression of OCTN1 in many cells and tissues indicate the possible 
important physiological functions of this free amino acid.  
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Structure and content 
Mushrooms are one of the great sources of ergothioneine (Cheah, Feng, Tang, Lim, & 
Halliwell, 2016; Cheah & Halliwell, 2012; N Joy Dubost et al., 2006; N. Joy Dubost et al., 2007; 
Kalaras et al., 2017). N. Joy Dubost et al. (2007) analyzed the ergothioneine concentration in six 
mushrooms including Agricus bisoporus (white, brown, and portabella), Lentinus edodes, 
Grifola frondosa, and Pleurotus osteratus. The ergothioneine concentration ranged from 0.21 to 
2.6 mg/g dry weight; the highest value was detected in Pleurotus osteratus and the lowerst value 
was detected in white button mushroom (N. Joy Dubost et al., 2007). S.-Y. Chen, Ho, Hsieh, 
Wang, and Mau (2012) also analyzed the ergothioneine content in the fruiting bodies of tweleve 
mushroom species and mycelia of seventeen mushrooms species. Ergothioneine was detected in 
all mushroom species; the species with very high ergothioneine content in fruiting bodies 
included Pleurotus citrinopileatus, P. ostreatus (Korea), P. ostreatus (Taiwan, China) and 
Pleurotus salmoneostramineus (2.85, 1.83, 1.46 and 1.24 mg/g dry weight, respectively), while 
the mushroom species with highest ergothioneine content in mycelia was Pleurotus eryngii 
(1514.6 mg/kg) (S.-Y. Chen et al., 2012). Overall the Pleurotus spp contain more ergothioneine 
than other species. Another study conducted by Kalaras et al. (2017) analyzed ergothioneine 
content in twelve mushroom species. The range of the ergothioneine content was 0.15-7.27mg/g 
dw with Boletus edulis having the highest content (Kalaras et al., 2017). Pileus were found to 
contain more ergothioneine than stipe tissues in those mushrooms that were assessed for both 
parts. A few mushroom species in Kalaras et al. (2017)’s study were also analyzed in S.-Y. Chen 
et al. (2012)’s study. However, ergothioneine content in S.-Y. Chen et al. (2012)’s study was 
higher than that in Kalaras et al. (2017)’s study. This is probably due to the sources of 
mushrooms which are affected by the growing environment, harvesting method and harvesting 
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time. Table 7 lists the ergothioneine content in several common edible mushrooms from different 
sources and studies. 
Table 9 L-ergothioneine Content in Commonly Cultivated Mushrooms 
Scientific names Common names L-ergothioneine 
content (mg/g DW) 
Sample origin Reference 
Agaricus bisporus 
(white) 
Button 
mushroom 
0.21 U.S. N. Joy Dubost et al. 
(2007) 
Agaricus bisporus 
(not specified) 
Button 
mushroom 
0.93 Taiwan, China S.-Y. Chen et al. 
(2012) 
Agaricus bisporus 
(brown) 
Button 
mushroom 
0.40 U.S. N. Joy Dubost et al. 
(2007) 
Lentinus edodes Shiitake 1.98 U.S. N. Joy Dubost et al. 
(2007) 
0.41 Taiwan, China S.-Y. Chen et al. 
(2012) 
0.40 Japan Ito et al. (2011) 
Pleurotus ostreatus Oyster 
mushroom 
2.59 U.S. N. Joy Dubost et al. 
(2007) 
0.94 Japan S.-Y. Chen et al. 
(2012) 
1.83 Korea S.-Y. Chen et al. 
(2012) 
1.46 Taiwan, China S.-Y. Chen et al. 
(2012) 
1.98 Japan Ito et al. (2011) 
Pleurotus eryngii King oyster 
mushroom 
0.62 Taiwan, China S.-Y. Chen et al. 
(2012) 
1.41 Japan Ito et al. (2011) 
Pleutotus 
citrinopileatus 
Golden oyster 
mushroom 
3.94 U.S. Kalaras et al. (2017) 
Flammulina velutipes Golden needle 
mushroom 
0.45 Taiwan, China S.-Y. Chen et al. 
(2012) 
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Health benefits of L- ergothioneine 
Ergothioneine is well known of its potential health functions including scavenging of free 
radicals, chelation of metals, cytoprotection, gene regulation, and immunomodulation (Akanmu, 
Cecchini, Aruoma, & Halliwell, 1991; Aruoma, Spencer, & Mahmood, 1999; Cheah & 
Halliwell, 2012; MITSUYAMA, 1999). Paul and Snyder (2009) studied the cytoprotective effect 
of ergothioneine using RNA interference technique. They found cells that lacked ergothioneine 
transporters were more susceptible to the oxidative stress, lipid and protein oxidation; in 
addition, ergothioniene transporters is accumulated in mitochondria which indicates its 
protective function against the superoxide produced by mitochondria (Paul & Snyder, 2009). 
They also suggested that ergothioneine may be a potential candidate of vitamin due to its special 
physiological function (Paul & Snyder, 2009). Another study conducted by B.-Z. Zhu et al. 
Figure 4. Tautomers of ergothioneine; ergothioneine 
predominately exists as thione form at physiological 
pH (Tang, Cheah, Yew, & Halliwell, 2018) 
Figure 3. Structure of ergothioneine 
(Melville, 1959)  
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(2011) investigated the cytoprotective effect of ergothioneine on copper-induced oxidative 
damage on DNA and protein in vitro. They found that ergothioneine exhibited strong dose-
dependent protection by forming the ergothioneine-copper complex (B.-Z. Zhu et al., 2011). 
Hseu et al. (2015) reported the protective effect of ergothioneine on UVA-irradiated 
human keratinocytes (skin cells). Their study demonstrated that nanomolar concentrations of 
ergothioneine (125-500 nM) was able to protect human keratinocytes from damages caused by 
UVA effectively by inhibiting generation of ROS, DNA strand breaks, DNA fragmentation, 
mitochondrial dysfunction, and cell apoptosis (Hseu et al., 2015). They found that ergothioneine 
prevented cell apoptosis by downregulating caspase-3/-9 activation and dysregulating Bcl-2/Bax 
expression (caspase-3/-9 and Bcl-2/Bax are key apoptotic regulatory proteins) (Hseu et al., 
2015). In addition, their results showed that ergothioneine upregulated the antioxidant genes HO-
1, NQO-1, and 𝛾𝛾-GCLC by increasing the expression of Nfr2 and inhibiting the degradation of 
synthesized Nfr2, which is a nuclear factor that regulates the antioxidant genes (Hseu et al., 
2015). Furthermore, they found that induction of antioxidant genes and restore of glutathione in 
keratinocytes was due to the activation of the transcriptional signaling pathway Nrf2/ARE, 
which was further mediated by AKT and PKC pathways and ergothioneine was able to increase 
phosphorylation of AKT and PKC pathways.  (Hseu et al., 2015).  
Other studies report the immunomodulatory effect of ergothioneine (Cheah & Halliwell, 
2012; Martin, 2010; Yoshida et al., 2017). Martin (2010) investigated whether ergothioneine 
could inhibit the pro-inflammatory induction of adhesion molecules that are expressed in 
atherosclerosis. The results showed that ergothioneine at 0.1-0.3mM significantly inhibited the 
expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 
(ICAM-1) and endothelial-leukocyte adhesion molecule-1 (ELAM-1 or E-selectin) (Martin, 
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2010). This study suggests that ergothioneine-rich food sources such as mushrooms may 
effectively prevent CVD. Yoshida et al. (2017) found that ergothioneine has immune-enhancing 
properties which increased the TLR signaling of mouse bone marrow-derived macrophages. 
TLR-signal-mediated cytokine production including IL-6 and IL-12p40 was increased; 
furthermore, ergothioneine enhanced Th17 differentiation in CD4+ T cells (Yoshida et al., 2017). 
Apart from in vitro studies, there are also some epidemiological and in vivo studies that 
have demonstrated the physiological functions of ergothioneine either in animals or humans. 
Neuroprotective effect of ergothioneine has been widely studied. Cheah, Feng, et al. (2016) 
conducted an epidemiological study that investigated the association between ergothioneine and 
age and the association between ergothioneine and neurodegenerative disease. What they found 
is that the blood ergothioneine level was significantly lower in people older than 60 (Cheah, 
Feng, et al., 2016). They also found that people with mild cognitive impairment had significantly 
reduced ergothioneine level in blood compared with age-matched normal subjects (Cheah, Feng, 
et al., 2016). Their study suggests that ergothioneine may be closely associated with age-related 
neurodegenerative diseases. Song, Chen, Liao, Ou, and Tsai (2010) investigated the protective 
effect of ergothioneine on neuronal injury induced by cisplatin both in vitro and in vivo. Their 
results found that ergothioneine could significantly prevent neurotoxicity of pheochromocytoma 
(PC12) cells and primary cortical neuron (PCN) cells induced by cisplatin in vitro (Song et al., 
2010). Their in vivo study which used CBA mice as study models also showed neuroprotection 
by ergothioneine including reduced lipid peroxidation, restoring of actetylcholinesterase (AchE) 
and maintaining the balance between glutathione/glutathione disulfide ratio in brain tissues 
(Song et al., 2010). Ergothioneine showed significant restoration of learning and memory deficits 
in mice with neurotoxicity (Song et al., 2010). Another study conducted by N.-C. Yang et al. 
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(2012) investigated the protective effect of ergothioneine on neuronal injury induced by beta-
amyloid in mice. Accumulation of beta-amyloid is highly associated with Alzheimer’s disease. 
Their results showed that ergothioneine significantly prevented the accumulation of beta-amyloid 
in hippocampus and reduced lipid peroxidation at the same time(N.-C. Yang et al., 2012). In 
addition, it restored the acetylcholinesterase activity and maintained the glutathione/glutathione 
disulfide ratio and superoxide dismutase activity in brain tissues (N.-C. Yang et al., 2012). The 
behavioral tests of mice showed improvement of memory and learning abilities in mice treated 
with ergothioneine (N.-C. Yang et al., 2012). Their research shows the potential of ergothioneine 
to improve the symptoms of Alzheimer’s disease.   
Regarding to the antioxidant and anti-inflammation of ergothioneine, Repine and Elkins 
(2012) reported reduced lung injury and lung inflammation in cytokine insufflated rats that were 
fed with ergothioneine either before or after insufflation. They suggested that ergothioneine 
which exhibits high antioxidant activity could be a potential treatment for acute respiratory 
distress (ARDs) because lung inflammation and lung oxidative stress are the major factors of 
ARDs (Repine & Elkins, 2012). Cheah, Tang, Yew, Lim, and Halliwell (2016) conducted a 
placebo-controlled, double-blind human clinical study which investigated the pharmocokenetics 
of ergothioneine in healthy human subjects and its antioxidant activity by examining selective 
biomarkers of oxidative damage and inflammation. Their results showed that plasma and whole 
blood ergothioneine concentrations significantly increased and the excretion of ergothioneine in 
urine was relatively low, which indicated that ergothioneine was well absorbed and retained in 
the body (Cheah, Tang, et al., 2016). The examination of biomarkers of oxidative damage and 
inflammation showed that there was some decreasing in these biomarkers but was not significant 
(Cheah, Tang, et al., 2016). They concluded that absorption and retention of ergothioneine in 
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human bodies suggests that it may play important physiological roles in the body however its 
antioxidant activity may be more potent under oxidative stress but not in healthy condition 
(Cheah, Tang, et al., 2016).  
Although the physiological functions and health benefits of ergothioneine have been 
extensively studied by many researchers, especially its antioxidant activity and cytoprotective 
effect both in vitro and in vivo, the exact mechanisms of how ergothioneine ameliorates the 
symptoms of many diseases are still under investigation. Nevertheless, ergothioneine from 
dietary sources, especially from mushrooms which contain high amount of ergothioneine, has 
large potential to provide different health benefits.  
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CHAPTER 6 
 
SAFETY OF MUSHROOM CONSUMPTION 
Although mushrooms are a good source of different nutrients and bioactive compounds 
which possess many health benefits, safety issues related to mushroom consumption should be 
taken seriously since inadequate consumption could lead to health problems. Apart from the 
accidents of consuming poisonous mushrooms which are usually due to wrong identification of 
wild mushroom species, another important safety issue is the presence of excessive heavy metals 
in those edible mushrooms especially wild edible mushrooms. There have been a few studies that 
assessed the heavy metal content in wild edible mushrooms in different countries. X.-H. Chen, 
Zhou, and Qiu (2009) analyzed the heavy metal content in 11 mushroom species collected from 
three regions in southern part of China, in which 5 were from the urban area and 6 were from the 
rural areas. Their results indicated that the five wild mushroom species collected from the urban 
area had high contamination of Pb, Cd, and Hg; the highest concentration of Pb, Cd and Hg 
reached 10.8 mg/kg in Calvatia craniiformis, 91.8 mg/kg in Macrolepiota crustosa and 3.92 
mg/kg in Agaricus subrufescens respectively. Some of them had heavy metal content far exceed 
the Chinese limit value (Pb limit: 1.0 mg/kg; Cd limit: 0.2 mg/kg; Hg limit: 0.1 mg/kg) (USDA 
Foreign Agricultural Service, 2018) . They concluded that consumption of these mushrooms 
from the urban area could possess health risks to humans and the source of contamination was 
mainly the automobile pollution (X.-H. Chen et al., 2009). Similarly, B. Liu et al. (2015) 
evaluated the heavy metal contamination of 8 wild edible mushroom species from 16 locations in 
Yunnan Province, which is a big supplier of wild edible mushrooms in China. They found that 
the highest value of As was 11.86 mg/kg in Tuber indicum Cooke et Massee, the highest value of 
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Cd was 2.88 mg/kg in Tricholoma matsutake and the highest value of Pb was 10.18 mg/kg in 
Russula vinosa Lindbl (B. Liu et al., 2015). Their results indicated that the concentrations of As, 
Pb and Cd in all 8 species were higher than the national standard value (Pb limit: 1.0 mg/kg; Cd 
limit: 0.2 mg/kg; As limit: 0.5mg/kg) (USDA Foreign Agricultural Service, 2018). The 
consumption of these contaminated mushrooms could lead to serious health problems and the 
source of contamination was very likely due to the rapid industrialization in Yunnan Province 
(B. Liu et al., 2015). Another study conducted by Schlecht and Säumel (2015) collected large 
amount of samples of 18 wild edible mushroom species from different habitats and 16 
commercial cultivars of Agricus bisporus that were exposed to high traffic in the city of Berlin, 
Germany. Their purpose was to assess the health risks of consumption of mushrooms from the 
urban area that may have excessive accumulation of heavy metals due to pollutions (Schlecht & 
Säumel, 2015). Their results showed that the highest value of Pb reached 51.6 mg/kg in M. 
procera and the highest value of Cd reached 67.6 mg/kg in B. recticulatus. They suggested that 
the high traffic burden is the major cause of the accumulation of the heavy metals in the 
mushrooms and consumption of these mushrooms should be limited due to the potential health 
risks (Schlecht & Säumel, 2015). 
Heavy metal contamination due to pollutions from industries and increased number of 
vehicles has been a growing safety problem for consumption of wild edible mushrooms. The 
consumption of wild edible mushrooms especially those in the urban areas should be limited to 
avoid health risks from the excessive heavy metals in these mushrooms.  
Apart from heave metal contamination, natural toxins in mushrooms is another safety 
concern. Misidentification of poisonous wild mushrooms as edible ones could lead to severe 
poisoning effects such as renal failure. Leathem, Purssell, Chan, and Kroeger (1997) reported 
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four cases of mushroom poisoning which lead to renal failure; it was highly possible because of 
misidentification of Amanita smithiana as pine mushrooms and Amanita smithiana is a 
poisonous mushroom which contains nephrotoxic compounds (Leathem et al., 1997). Other 
Amanita spp. such as Amanita phalloides (Death cap) and Amanita muscarius (Fly agaric) are 
both poisonous mushrooms that contain phallotoxins, virotoxins and amatoxins (Garcia et al., 
2015; Sadler, 2003). These toxins target several organs but mainly liver and kidney and the 
intoxication symptoms include gastrointestinal disorders, jaundice, seizures and coma (Garcia et 
al., 2015; Sadler, 2003). There is a high possibility that ingestion of these poisonous mushrooms 
can finally lead to death.  
Last but not least, some edible mushroom species can be poisonous when ingested 
together with other food or beverage. One well-known example is Coprinus atramentarius (Ink 
caps), which is a safe edible mushroom when cooked and eaten alone but can cause poisoning 
when combined with alcohol (Reynolds & Lowe, 1965). Symptoms of intoxication include 
flushing, palpitation, dyspnea, hyperventilation,  achycardia, and nausea (Reynolds & Lowe, 
1965). 
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CHAPTER 7 
 
CONCLUSION 
Extensive research on potential health benefits of different bioactive compounds sheds a 
light on mushrooms which has a great potential to be included as part of a healthy diet. Recent 
years the research focus of mushrooms has shifted from medicinal to edible ones since many 
bioactive compounds such as non-digestible long polysaccharides, phenolic compounds, 
terpenoids, and ergothioneine can be commonly found in edible mushrooms. Compared with 
medicinal mushrooms, edible mushrooms, especially those commercially cultivated ones, are 
affordable and easily accessible for most people. This review first discusses about the basic 
nutritional values and major bioactive compounds in some common edible mushrooms. Then it 
evaluates the structures, contents and major health benefits of three groups of important bioactive 
compounds in mushrooms including beta-glucans, phenolic compounds and L-ergothioneine. 
Lastly, the safety of mushroom consumption is also briefly reviewed. The collective information 
about edible mushrooms in this article could help understand the potential benefits of daily 
consumed mushrooms.  
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